Virax Biolabs Group Limited Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Accounts receivable

12 Months Ended

Mar. 31, 2022

Note 9 — Accounts receivable


	As of March 31,
	2022		2021
Accounts receivable		—		928
Less: provision for impairment of account receivables		—		—
Net account receivables		—		928
Current Accounts receivables		—		928